Differential B- and T-cell activation in Wegener’s granulomatosis
- 31 May 1999
- journal article
- research article
- Published by Elsevier
- Vol. 103 (5) , 885-894
- https://doi.org/10.1016/s0091-6749(99)70434-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Animal models of anti-neutrophil cytoplasmic antibody associated vasculitisKidney International, 1998
- Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's GranulomatosisNew England Journal of Medicine, 1996
- Murine CD38: an immunoregulatory ectoenzymeImmunology Today, 1995
- Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.Annals of the Rheumatic Diseases, 1993
- Elevated serum levels of soluble interleukin‐2 receptor in patients with Wegener's granulomatosis. Association with disease activityArthritis & Rheumatism, 1992
- T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitisClinical Immunology and Immunopathology, 1992
- Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2Journal of Autoimmunity, 1991
- Predominance of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disordersClinical and Experimental Immunology, 1991
- Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis?Immunology Today, 1991
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981